HLA-A*0201-restricted CTL epitope of a novel osteosarcoma antigen, papillomavirus binding factor
<p>Abstract</p> <p>Background</p> <p>To develop peptide-based immunotherapy for osteosarcoma, we previously identified papillomavirus binding factor (PBF) as a CTL-defined osteosarcoma antigen in the context of HLA-B55. However, clinical application of PBF-based immunotherapy requires identification...
Gardado en:
| Principais autores: | , , , , , , , , , , |
|---|---|
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado: |
BMC
2009-06-01
|
| Series: | Journal of Translational Medicine |
| Acceso en liña: | http://www.translational-medicine.com/content/7/1/44 |
| Tags: |
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!
|